Background Restorative proctocolectomy (RPC) is the criterion standard surgical treatment for ulcerative colitis (UC). Restorative proctocolectomy is indicated for UC that is refractory to medical treatment, for emergency conditions, and in case of neoplastic transformation. The procedure substantially reduces the risk of UC-associated dysplasia/neoplasia. However, after RPC surgery, even with mucosectomy, cancers of the pouch and/or the analtransitional zone (ATZ) have been reported with increasing frequency since the first report in 1984. This review highlights pouch-related dysplastic and neoplastic transformation, prevalence and adverse events, risk factors and surveillance following surgery for UC. Methods Reports in the literature about patients undergoing pouch surgery from different institutions reported through May 2010 were reviewed to identify patients who developed these complications, and an attempt was made to develop a rational follow-up policy based on the data available. Results To date, there are 43 reported cancers of the pouch or inlet after RPC for UC: 16 from retrospective series, 1 from a prospective study, and 26 in case reports. Thirty patients underwent mucosectomy and 13 had stapled anastomoses. To date, the number of 28 patients has been diagnosed with dysplasia after RPC for UC. Mucosectomy was performed in 27 of them and in 1 a stapled anastomosis was constructed without mucosectomy. In all cases reviewed, the time interval from the onset of UC to dysplasia/neoplasia was over 10 years. Conclusion Neoplastic lesions occurring in UC patients after RPC have been shown to be absolutely inevitable. Even mucosectomy does not completely eliminate the risk. There is little evidence to support routine biopsy of the ileal mucosa or the anal-transition zone except in patients with histological type C changes, sclerosing cholangitis, and unremitting pouchitis in the ileal mucosa. Such patients should be selected for endoscopic surveillance to detect dysplasia preceding pouch adenocarcinoma.
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Keywords Ulcerative colitis Á Restorative proctocolectomy Á Mucosectomy/stapled anastomosis Á Dysplasia/adenocarcinoma etiology Background One-third of patients with ulcerative colitis (UC) will eventually require surgery [1, 2] because of either disease refractory to medical treatment, dysplasia or cancer (found during screening colonoscopy) or, in children or adolescents, growth retardation. In any of the aforementioned circumstances, three surgical options are recommended: conventional total proctocolectomy with permanent ileostomy (TPC), restorative proctocolectomy (RPC) with ileal pouch anal anastomosis (IPAA), and total abdominal colectomy with ileorectal anastomosis (IRA) [3] . IIleorectal anastomosis is only suitable for the few patients whose rectum is relatively free of inflammation and who do not have dysplasia or established cancer in the rectum [4] . Conventional proctocolectomy leaves the patient with a permanent ileostomy [5] . Restorative proctocolectomy is now the standard criterion surgical procedure for treating UC [6] . The indications for each procedure and the surgical options usually chosen are colectomy with IRA or RPC [7] . The success of RPC is largely dependent on careful patient selection, and accurate diagnosis with meticulous surgical technique is of the utmost importance [3] . Excision of the entire colon and rectum with mucosectomy of the residual anorectal stump is intended to achieve complete removal of all disease-prone mucosa while maintaining transanal fecal continence [3, 7] . The procedure, however, may inadvertently leave small islands of residual mucosa [3, 7] . It is therefore indisputable that ileo-anal pouch mucosa and the anorectal mucosa below the ileo-anal anastomosis at the anal-transitional zone (AZT) are at risk of developing cancer [8] [9] [10] . This review highlights the experience in the literature about the incidence of ileal pouch-related dysplasia and/or cancer following RPC for UC.
Methods
A systematic literature search was conducted to identify retrospective studies and reports of similar cases, and comparative studies reporting post-operative early and late ileal pouch adenomas and adenocarcinoma adverse events were reviewed. Patients undergoing RPC surgery for UC from 1975 through June 2009 were prospectively enrolled. Institutional Review Board approval was obtained by each of the participating research institutions. The US National Library of Medicine database (MEDLINE), the Excerpta Medica database (EMBASE), the Cochran Library, and GoogleÒ search engine were searched for published articles on ''ulcerative colitis,'' ''colectomy,'' ''restorative proctocolectomy,'' ''ileoanal anastomosis,'' ''ileal pouches,'' ''villous adenomas,'' ''adenocarcinoma,'' ''dysplasia,'' ''metaplasia,'' ''pouch dysplasia,'' ''pelvic pouch,'' and ''pouch neoplasia.'' The initial search covered the period from January 1975 through December 2007. A second search was performed for the period from January 2008 through May 2010 to update the initial search. The search excluded articles not in English and non-human studies, as well as editorials. Additional articles were identified by cross-referencing papers retrieved in the initial search. Papers were included on the basis of most recent available evidence for each specific point of interest. Agreement about classification was assessed with the k value during the title review and abstract review. If the k value was C0.6, the titles were reviewed, divided into 2 sets; each was reviewed by only 1 of the 2 researchers. If the k value was \0.6, reviewers discussed discrepancies followed by other assessments of agreement. A similar process for abstract review was conducted, with an increased k value of 0.7 required for acceptance. The same authors involved in the original title, abstract, and article review process conducted hand searches of bibliographies from accepted articles and review articles. These hand searches resulted in the retrieval of a limited number of additional articles for review.
Results
The summary of all reported pelvic pouch-related cancer and dysplasia following RPC for UC is shown in Figs (Fig. 1 ) . Out of the 43 known patients with pouch-related cancer, 11 had cancer originating from the pouch body and 32 had cancer originating from the AZT . Malignancy following RPC appeared after mucosectomy in 30 patients and in 13 patients following stapled anastomosis (Fig. 1) .
Branco et al. observed that in patients with dysplasia or cancer at the original resection and/or those who presented at an older age, there was a shorter interval to the development of post-UC-RPC cancer than in other patients [35] . The median time until dysplasia/cancer was 3 years (mean 4.3, range 1.3-14) in the 9 patients who originally had cancer versus 6.5 years (mean 7.7, range 2-18) in the 12 patients who originally had low-or highgrade dysplasia and 6.5 (mean 8.6, range 2-19) in the 9 patients who had no neoplasia. Among the 21 patients who underwent surgery on account of cancer or dysplasia, 23% (n = 5) of the original lesions had occurred above the rectum [35] . Most studies have shown that the incidence of dysplasia or cancer after RPC is strongly associated with the duration of UC disease prior to colectomy and/or the presence of dysplasia or cancer in the proctocolectomy specimen [36, 37] . In all reported cases ( Fig. 1) , the interval from diagnosis of UC until RPC was over 10 years. Other factors observed to be associated with dysplasia and cancer of the pouch included longterm chronic inflammation (pouchitis, proctitis, and cuffitis) [38] , histological type C changes [39, 40] , and the presence of sclerosing cholangitis [41] .
Ileal pouch cancer risk after RPC for UC Conventional hand-sewn anastomosis after mucosectomy and double-stapled anastomosis without mucosectomy are the most common techniques used in fashioning intestinal anastomoses [3, 42] . Controversy persists over the techniques used in ileo-anal anastomosis (IAA). The majority of surgeons [42] feel that with the double-stapled anastomosis, there are fewer anastomotic complications and better rectal continence is achieved. However, a cuff of rectal mucosa is retained [43] (Fig. 3a) , which is the main argument used by the opponents of the double stapling technique [15, 19] . It seems clear though, despite controversies, that mucosectomy ( Fig. 3b) does not always rule out the subsequent development of pouch-related cancer [28, 30] . With the hand-sewn anastomosis, little to no rectal mucosa is left behind [44] . Microscopic islands of retained rectal mucosa, however, have been reported in 20% of patients [44] . This technique has largely been abandoned in patients not at high risk and replaced by the double-stapled technique, which is said to offer better functional results [3, 45] . Reports have shown that the remaining rectal tissue [41, 46] , the ileal pouch itself [43, 47] , and the pouch outlet after mucosectomy are the sites where cancer is most likely to develop. One should bear in mind that a hand-sewn IPAA is more difficult to survey than a stapled one and that there is often stenosis and leakage that can cause excoriation and tenderness of the perianal skin. In a recent case report [48] , an anal-canal mucinous adenocarcinoma with lymph node metastasis was diagnosed 7 years after ileal pouch excision.
Dysplasia and neoplasia of the pouch mucosa
The incidence of dysplasia in pouch mucosa has been reported [49] . Studies from Karolinska University [40, 50] followed 94 patients prospectively over a median period of 6.3 years (range 3-14 years). Eight patients developed low-grade dysplasia. All had a type C mucosal pattern with chronic pouchitis and deoxyribonucleic acid (DNA) aneuploidy, which raised the possibility of future malignant transformation. Barrett [51] studied 30 UC-RPC patients [49] . A collaborative study from Sweden and United Kingdom [8] reported long-term mucosal adaptation patterns and the incidence of dysplasia in 40 patients at a mean interval of 30 years following a Kock continent ileostomy for UC. Type A and type B mucosal patterns, based on the criteria described by Lofberg et al. [50] and Setti Carraro et al. [52] , were found in 29 patients and a type C pattern was observed in 11 patients. There were 3 cases of dysplasia, which were low grade and found Tech Coloproctol (2011) 15:7- 16 11 exclusively in the type C group. No patients were found to have high-grade dysplasia or adenocarcinoma. Due to a significant disagreement among the pathologists in reporting low-grade and indefinite categories of dysplasia, the incidence of indefinite and low-grade dysplasia of 27.5 and 7.5% reported by one group of pathologists was reported by the second group to be 7.5 and 5%, respectively. Herline et al. [53] reviewed 222 UC-RPC pouch biopsy specimens from 160 patients for an average follow-up of 8.4 years. Surveillance of over 1,800 pouches identified only one case of focal, low-grade dysplasia. A group from Mount Sinai School of Medicine, New York, NY [54] , reports adenocarcinoma arising in an ileal pouch 29 years after UC diagnosis and 6 years after RPC.
In an Italian study, pouchoscopies were performed with biopsies taken from the pouch [55] during follow-up of 55 UC-RPC patients for a median of 14 years (range 10.7-19.8 years). Interestingly, there were no patients with dysplasia in the 440 biopsy samples obtained and all were negative for p53 antigen [55] . Similar observations were made in a study on 45 UC-RPC patients followed up with clinical examination and pouch endoscopy, including mucosal biopsies [56] . The median duration of UC until surgery was 6 years (range 1-28), and the median time interval from diagnosis of UC until follow-up was 24.8 (range 17-46) years. Neither high-grade dysplasia nor invasive carcinoma was diagnosed in these patients. It appears that cancer in the UC-RPC population is relatively rare and related to the duration of disease rather than to the interval from RPC [41] .
Dysplasia and neoplasia of the residual anorectal mucosa
The IAA is made between the ileal pouch and either the anal canal or the lower rectum [57] . The level depends on whether a manual anastomosis with mucosectomy or a stapled anastomosis with mucosectomy has been performed [3] . Using the former technique, the level can be controlled directly by the level at which the mucosectomy is made, while this is more difficult when carrying out a stapled anastomosis [58] . Therefore, in some patients, there may be a considerable length of anorectal mucosa below the anastomosis, which is considered at risk of neoplastic transformation [41] . Zmora et al. [34] , in their recent paper, reported that one patient was found to have cancer cells in random biopsies from the rectal cuff. Ten years prior, she had undergone proctectomy and IPAA due to T2NO rectal cancer and 28 years prior total abdominal colectomy with ileorectal anastomosis due to a right-sided T2NO colon cancer. Inflamed anorectal mucosa following stapled anastomosis may be symptomatic in up to 25% of patients [59] , indicating that the so-called strip proctitis or cuffitis in the residual mucosa may be clinically important. The length of this segment will vary according to the level of the IAA, and it may be referred to as the ATZ. Thompson Fawcett et al. [60] showed considerable variation in the position and extent of the ATZ both from individual to individual and to some extent within the same individual. In almost all patients, the IAA is more proximal leaving a varying length of columnar epithelium. When referring to the epithelium below the ileoanal anastomosis, ''ATZ'' is therefore not accurate and should be replaced by the phrase ''residual anorectal mucosa.'' Using this definition, the risk of dysplasia or cancer occurring below the IAA after both stapled and/or hand-sewn anastomosis reaches 16% [61, 62] .
In a study from St. Mark's Hospital [63] on the incidence of dysplasia in the mucosectomy specimen taken from the anorectal stump during RPC of 118 patients with UC, 12 patients (10%) had dysplasia in the colon specimen and dysplasia in the anorectal mucosa was found in 3 patients. There was a positive correlation between these data and the presence of carcinoma in the surgical specimen and the duration of disease. A group from the Cleveland Clinic Foundation [64] [65] [66] reported a significant incidence of dysplasia in the ATZ of UC-RPC patients. Low-grade dysplasia was found in 3.1% of patients and had developed over a median period of 1.3-6.4 years, postoperatively. No association was found, however, between dysplasia and the duration of UC, the use of double-stapled versus single-stapled technique or the distance of the anastomosis from the pectineal line. Dysplasia developed in 7 (3%) of 210 patients. High-grade dysplasia was seen in one patient, and the risk of dysplasia was significantly increased in patients with prior cancer or dysplasia in the colon. In a larger series [66] , from the United States, 289 patients were followed by regular examinations and biopsies of the ATZ. Dysplasia was found in 8 (2.76%) patients at a median period of 9 months post-RPC. High-grade dysplasia was seen in two patients, one with a history of chronic pouchitis and the other with preoperative dysplasia in the colon. All 8 of the patients with dysplasia were either followed closely or underwent mucosectomy with pouch advancement and re-anastomosis via an endo-anal approach. No patient developed carcinoma. There was no association between the occurrence of dysplasia and gender, age, preoperative disease duration, or extent of colitis. However, dysplasia was significantly associated with cancer or dysplasia in the colon or rectum in the proctocolectomy specimen. A study conducted at John Radcliffe Hospital, in the United Kingdom [62] , assessed the risk of dysplasia and the presence of aneuploidy in the columnar cuff epithelium after stapled IAA in 113 patients with UC. The reported mean follow-up after pouch formation was 2.5 years. Successful columnar cuff biopsies were performed in 93% of patients, and no patient with dysplasia was found. Two biopsy specimens from one patient showed aneuploidy. Another study [67] reviewed 135 UC-RPC patients for a median of 56 months and the median interval from the diagnosis of disease to RPC was 8.8 years. There was no evidence of either dysplasia or carcinoma in the anorectal mucosa up to 12 years after surgery, and the authors suggested that cuff surveillance in the first decade after stapled RPC, in the absence of dysplasia or carcinoma in the original colectomy specimen, may be unnecessary.
Possible associated factors for neoplastic transformation
Five factors associated with neoplastic transformation following RPC for UC have been observed, namely dysplasia or cancer in the operative specimen; interval from the diagnosis of UC; type C mucosal changes; extra intestinal manifestations (EIM); and manual versus stapled anastomotic technique.
Dysplasia or cancer in the operative specimen
Most studies have shown that the incidence of dysplasia following RPC is increased with a preoperative history of dysplasia or carcinoma, or a finding of the same in the original surgical specimen [49] . Twelve of the 17 patients (71%%) who were reported to have developed cancer in the anorectal mucosa or in the ileo-anal pouch had dysplasia or cancer identified before RPC or found subsequently in the surgical specimen. This appears to be the most important predisposing factor for the transformation and/or development of neoplasia following RPC.
Interval from the diagnosis of UC Studies [68] have shown that the vulnerability of colorectal cancer in patients with long-standing UC increases with time and is related to the anatomical extent of the disease in the surgical specimen [69] . Pouch-related cancers did not occur in any of the patients before 10 years from the diagnosis of UC, and the median interval was 20 years. The interval from RPC (median 5 years; range 1.3-18 years) varied more, and it seems likely that the time of UC diagnosis is the vital interval when considering surveillance.
Type C Mucosal change A type C mucosal pattern of the pouch mucosa is observed to be associated with chronic pouchitis and also with dysplasia and aneuploidy. While Setti Carraro et al. [52] observed that these patients can be identified within months of RPC by histopathological examination of the biopsy material, other authors [49] did not demonstrate an association between chronic pouchitis and dysplasia and some have not found any dysplasia at all in patients undergoing pouch surveillance [70] .
Extraintestinal manifestations
The association between type C changes and extraintestinal manifestations (EIM), including primary sclerosing cholangitis (PSC) and their apparent relationship with dysplasia, suggests that patients with type C changes are at risk of developing pouch-related neoplastic transformation [50] .
Manual versus stapled anastomotic technique
To date, there are reports of 43 patients with carcinoma in the anorectal mucosa [19] following RPC for UC. In 13 of these patients, cancer developed after stapled anastomosis without mucosectomy [15, 19, 71] and in 30 after mucosectomy and hand-sewn anastomosis, indicating that malignancy can develop after either form of anastomosis. There has been no prospective study that reported the cumulative risk of carcinoma in the anorectal mucosa based on life table analysis. It is possible that patients who had received a stapled anastomosis [48, 63, 67, 72] have a significant risk in the long term when there is residual rectal mucosa, particularly if dysplasia was present preoperatively.
Surveillance for neoplastic transformation
Recommended guidelines have recently been developed at St. Mark's Hospital [7] to provide consistent evidencebased care by pouch specialist practitioners. Surveillance flexible pouchoscopy is recommended annually in patients at high risk of neoplastic transformation and every 5 years in others [41] . Delaini et al. [73] suggest that intense follow-up and research-based evidence are important in maintaining RPC as the criterion standard procedure for surgical treatment of UC. Although RPC risk surveillance is costly [41] , the good news is that the incidence of carcinoma in the ileal pouch or anorectal mucosa appears to be rare during the first 10 years after RPC. It is not clear whether there is a metaplasia-dysplasia-carcinoma sequence [18, 56] following RPC, or whether there is simply sporadic cancer in the ileal pouch in certain, susceptible individuals. The literature, however, suggests that patients with preoperative neoplastic transformation, type C pouch mucosal changes, PSC, and antecedent dysplasia/ carcinoma are at higher risk of developing dysplasia or invasive adenocarcinoma than the normal population undergoing RPC. These features merit concern and both the pouch and the anorectal mucosa should be monitored by endoscopic biopsy [41] to identify the appearance of type C changes. This is particularly important in patients who have had UC for 10 years, in which case, pouchoscopy with multiple biopsies and anorectal mucosal biopsies should be considered. Alternative forms of surveillance have been proposed by Elkowitz et al. [74] , including testing for p53 over-expression and aneuploidy of biopsies, in addition to histopathological assessment for dysplasia. A method of surveillance of the anorectal mucosa using highmagnification chromatoscopic pouchoscopy has been described [17] . The procedure gives an accurate assessment of the microanatomy of the anorectal, permitting accurate biopsy targeting. It is possible that these approaches may become part of future surveillance.
Conclusion
Although RPC in UC patients with or without cancer or dysplasia can safely be performed with a reasonably high success rate, these patients may later develop cancer in the ATZ. Even mucosectomy does not rule this out. A preoperative diagnosis of dysplasia or cancer of the colon or rectum is an associated factor for pouch-related dysplasia or adenocarcinoma. There is little evidence to support routine biopsy of the ileal and the anorectal mucosa in UC-RPC patients, except in those with dysplasia or carcinoma in the original specimen. Patients with type C ileal mucosal changes and those with sclerosing cholangitis should be selected for surveillance. Patients with long-standing pouchitis, proctitis, and cuffitis are at risk of developing adenocarcinoma if inflammation is found. Surveillance may involve multiple biopsies of the ileal reservoir and the anorectal mucosa below the ileo-anal anastomosis.
